Scout Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,385
Closed -$19.3M 247
2021
Q4
$19.3M Sell
29,385
-688
-2% -$432K 0.28% 119
2021
Q3
$18.7M Buy
30,073
+8,405
+39% +$5.65M 0.28% 125
2021
Q2
$13.7M Sell
21,668
-128
-0.6% -$70.7K 0.2% 156
2021
Q1
$10.7M Buy
21,796
+2,149
+11% +$1.08M 0.16% 204
2020
Q4
$9.82M Hold
19,647
0.18% 202
2020
Q3
$7.72M Sell
19,647
-265
-1% -$98K 0.17% 198
2020
Q2
$6.57M Sell
19,912
-399
-2% -$116K 0.16% 199
2020
Q1
$4.92M Buy
+20,311
New +$5.3M 0.15% 187
2019
Q4
Sell
-56,759
Closed -$15.4M 286
2019
Q3
$15.4M Buy
+56,759
New +$15.8M 0.31% 116

Other funds holding IDXX

Scout Investments's IDXX Position: Q1 2022 in Review

Scout Investments sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 29,385 shares — an estimated $19.3M sold.

Scout Investments first reported a position in IDXX in Q3 2019 and held it in 9 quarters. The position peaked at $19.3M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Scout Investments reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Scout Investments sold 29,385 Idexx Laboratories shares in Q1 2022, an estimated $19.3M.
  • Scout Investments first reported a position in Idexx Laboratories in Q3 2019 and held it in 9 quarters.
  • Scout Investments's Idexx Laboratories position peaked at $19.3M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Scout Investments's 13F filing for Q1 2022, filed 14 Apr 2022.